Parallax Volatility Advisers, L.P. Corcept Therapeutics Inc Put Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $1.4 Million - $1.71 Million	-70,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$23.49 - $30.56 $1.64 Million - $2.14 Million	70,000 New	70,000 $1.67 Million
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $2.15 Million - $3.27 Million	-190,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.27 - $15.65 $1.78 Million - $2.27 Million	145,300 Added 322.89%	190,300 $2.67 Million
Q2 2018 Aug 14, 2018	BUY	$15.3 - $19.69 $688,500 - $886,050	45,000 New	45,000 $707,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.55B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.